293 related articles for article (PubMed ID: 9635444)
1. Efficacy of ivermectin against Strongyloides stercoralis infection in jirds (Meriones unguiculatus).
Sithithaworn P; Fujimaki Y; Mitsui Y; Prasanthong R; Yutanawiboonchai W; Aoki Y
Exp Parasitol; 1998 Jun; 89(2):205-12. PubMed ID: 9635444
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs.
Alvarez L; Lifschitz A; Entrocasso C; Manazza J; Mottier L; Borda B; Virkel G; Lanusse C
J Vet Pharmacol Ther; 2008 Jun; 31(3):230-9. PubMed ID: 18471144
[TBL] [Abstract][Full Text] [Related]
3. Ivermectin treatment of naturally acquired and experimentally induced Strongyloides stercoralis infections in dogs.
Mansfield LS; Schad GA
J Am Vet Med Assoc; 1992 Sep; 201(5):726-30. PubMed ID: 1399774
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy assessment of the albendazole-ivermectin combination in lambs parasitized with resistant nematodes.
Entrocasso C; Alvarez L; Manazza J; Lifschitz A; Borda B; Virkel G; Mottier L; Lanusse C
Vet Parasitol; 2008 Aug; 155(3-4):249-56. PubMed ID: 18571329
[TBL] [Abstract][Full Text] [Related]
5. Strongyloides stercoralis: high worm population density leads to autoinfection in the jird (Meriones unguiculatus).
Nolan TJ; Bhopale VM; Rotman HL; Abraham D; Schad GA
Exp Parasitol; 2002 Mar; 100(3):173-8. PubMed ID: 12173402
[TBL] [Abstract][Full Text] [Related]
6. Association of a sex-related difference of Strongyloides stercoralis-specific IgG4 antibody titer with the efficacy of treatment of strongyloidiasis.
Satoh M; Toma H; Kiyuna S; Shiroma Y; Kokaze A; Sato Y
Am J Trop Med Hyg; 2004 Jul; 71(1):107-11. PubMed ID: 15238698
[TBL] [Abstract][Full Text] [Related]
7. Immunity to a challenge infection of Strongyloides stercoralis third-stage larvae in the jird.
Nolan TJ; Rotman HL; Bhopale VM; Schad GA; Abraham D
Parasite Immunol; 1995 Nov; 17(11):599-604. PubMed ID: 8817607
[TBL] [Abstract][Full Text] [Related]
8. [An overview of Strongyloides stercoralis and its infections].
Ardiç N
Mikrobiyol Bul; 2009 Jan; 43(1):169-77. PubMed ID: 19334396
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of ivermectin in the treatment of children parasitized by Strongyloides stercoralis].
Ordóñez LE; Angulo ES
Biomedica; 2004 Mar; 24(1):33-41. PubMed ID: 15239599
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal effects of ivermectin treatment in rats infected with Strongyloides venezuelensis.
Mendonça JC; Gama LA; Hauschildt AT; Corá LA; Américo MF
Acta Trop; 2019 Jun; 194():69-77. PubMed ID: 30914242
[TBL] [Abstract][Full Text] [Related]
11. Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature.
Donadello K; Cristallini S; Taccone FS; Lorent S; Vincent JL; de Backer D; Jacobs F
Int J Antimicrob Agents; 2013 Dec; 42(6):580-3. PubMed ID: 24269075
[TBL] [Abstract][Full Text] [Related]
12. Loperamide modifies the tissue disposition kinetics of ivermectin in rats.
Lifschitz AL; Virkel GL; Sallovitz JM; Pis A; Imperiale FA; Lanusse CE
J Pharm Pharmacol; 2004 Jan; 56(1):61-7. PubMed ID: 14980002
[TBL] [Abstract][Full Text] [Related]
13. Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations.
Lifschitz A; Virkel G; Ballent M; Sallovitz J; Imperiale F; Pis A; Lanusse C
Vet Parasitol; 2007 Jul; 147(3-4):303-10. PubMed ID: 17524559
[TBL] [Abstract][Full Text] [Related]
14. Combined subcutaneous administration of ivermectin and nitroxynil in sheep: age/body weight related changes to the kinetic disposition of both compounds.
Moreno L; Ceballos L; Lifschitz A; Bistoletti M; Alvarez L; Lanusse C
Res Vet Sci; 2010 Apr; 88(2):315-20. PubMed ID: 19892381
[TBL] [Abstract][Full Text] [Related]
15. High Efficacy of Ivermectin for Strongyloidiasis Treatment.
Sengthong C; Pinlaor S; Yingklang M; Haonon O; Jantawong C; Pinlaor P; Sithithaworn P; Hongsrichan N
Am J Trop Med Hyg; 2024 May; 110(5):951-952. PubMed ID: 38579698
[TBL] [Abstract][Full Text] [Related]
16. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
Marty FM; Lowry CM; Rodriguez M; Milner DA; Pieciak WS; Sinha A; Fleckenstein L; Baden LR
Clin Infect Dis; 2005 Jul; 41(1):e5-8. PubMed ID: 15937753
[TBL] [Abstract][Full Text] [Related]
17. Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition.
Ballent M; Lifschitz A; Virkel G; Sallovitz J; Lanusse C
J Vet Pharmacol Ther; 2007 Jun; 30(3):242-8. PubMed ID: 17472656
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of orally administered ivermectin in African elephants (Loxodonta africana): implications for parasite elimination.
Gandolf AR; Lifschitz A; Stadler C; Watson B; Galvanek L; Ballent M; Lanusse C
J Zoo Wildl Med; 2009 Mar; 40(1):107-12. PubMed ID: 19368248
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.
Pacanowski J; Santos MD; Roux A; LE Maignan C; Guillot J; Lavarde V; Cornet M
Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846
[TBL] [Abstract][Full Text] [Related]
20. Sex-related differences in the gastrointestinal disposition of ivermectin in the rat: P-glycoprotein involvement and itraconazole modulation.
Lifschitz A; Ballent M; Virkel G; Sallovitz J; Lanusse C
J Pharm Pharmacol; 2006 Aug; 58(8):1055-62. PubMed ID: 16872551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
